Role of miRs-143 and -145 in Prostate Cancer Bone Metastasis
Author Information
Author(s): Peng Xinsheng, Guo Wei, Liu Tiejian, Wang Xi, Tu Xiang'an, Xiong Dafu, Chen Song, Lai Yingrong, Du Hong, Chen Guangfu, Liu Guanglin, Tang Yubo, Huang Shuai, Zou Xuenong
Primary Institution: The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China
Hypothesis
The expression of certain microRNAs is associated with bone metastasis of prostate cancer.
Conclusion
miRs-143 and -145 are downregulated in bone metastatic prostate cancer and may serve as biomarkers for predicting metastasis.
Supporting Evidence
- miRs-143 and -145 were significantly downregulated in bone metastatic samples compared to primary prostate cancer.
- Downregulation of miRs-143 and -145 correlated with higher Gleason scores and PSA levels.
- Overexpression of miRs-143 and -145 reduced the migration and invasion of prostate cancer cells in vitro.
Takeaway
This study found that two tiny molecules called miRs-143 and -145 are important for understanding how prostate cancer spreads to bones, and they might help doctors tell how serious the cancer is.
Methodology
The study used miRNA microarray analysis and real-time PCR to compare miRNA expression in primary and metastatic prostate cancer tissues.
Potential Biases
Potential bias due to the retrospective nature of the study and the selection of samples.
Limitations
The study was limited by the small sample size and the focus on specific miRNAs.
Participant Demographics
Patients with primary prostate cancer and bone metastasis, with no significant age difference between groups.
Statistical Information
P-Value
p=0.012 for miR-143, p=0.014 for miR-145
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website